Answers are grounded in this paper and cite their sources.
Adrenocortical carcinoma (ACC) is an extremely rare endocrine cancer and the overall 5-year survival rate for such patients could only reach 16–47%. Most ACCs are hormone-secreting with prominent clinical symptoms, while over-secretion of pure sex hormone is even much rare, especially in adults. Here we report a case of a 74-year-old male patient admitted into our hospital for an adrenal incidentaloma and hypertension. Enhanced computed tomography (CT) scans showed a left adrenal mass with a maximum diameter of 15 cm, the maximum standardized uptake value of which was 15.2 on fluorine-18 fluorodeoxyglucose positron emission tomography CT ( 18 F-FDG PET/CT). On physical examination, he did not present with any signs or symptoms of Cushing’s syndrome or gynecomastia. Laboratory tests demonstrated dehydroepiandrosterone sulfate (DHEAS) levels 5-fold above the upper limit of normal, with other adrenal hormones within reference ranges—findings highly suggestive of ACC. Given the mass size, open en bloc resection of the mass, left kidney, and spleen was performed. Postoperative pathology confirmed the diagnosis of ACC with a Weiss score of 7. Immunohistochemistry of the tumor slides indicated that the tumor cells had characteristics of the zona reticularis. Further gene test revealed no pathogenic mutation within the mass. Local recurrence was identified 3 months postoperatively and progressed gradually during follow-up. At the 62-month telephone follow-up, the patient remained alive with normal daily activities and no lung metastasis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: